TerrAscend (TSNDF) Gross Margin Growth (1y) (2022 - 2026)

TerrAscend (TSNDF) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 128.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -22.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -503.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -543.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -271.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -9.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -8.00
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn -114.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -114.00
Dec 31, 2025 -74.00
Sep 30, 2025 114.00
Jun 30, 2025 148.00
Mar 31, 2025 590.00
Dec 31, 2024 -4,885.00
Sep 30, 2024 -260.00
Jun 30, 2024 -58.00
Mar 31, 2024 -81.00
Dec 31, 2023 5,641.00
Sep 30, 2023 657.00
Jun 30, 2023 1,293.00
Mar 31, 2023 1,700.00
Dec 31, 2022 -3,893.00
Sep 30, 2022 325.00
Jun 30, 2022 -1,891.00
Mar 31, 2022 -3,364.00